Hepatocyte growth factor (HGF): A new biochemical marker for acute myocardial infarction

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Heart and Vessels

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02766790PMID 9846810
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

  1997cited by this paper
• Emerging multipotent aspects of hepatocyte growth factor.

  1996cited by this paper
• Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.

  1996cited by this paper
• Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator.

  1995cited by this paper
• Serum hepatocyte growth factor levels in liver diseases: Clinical implications

  1995cited by this paper
• Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.

  1994cited by this paper
• Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII.

  1993cited by this paper
• Heparin as an inducer of hepatocyte growth factor.

  1993cited by this paper
• Biochemical Markers of Myocardial Injury Is MB Creatine Kinase the Choice for the 1990s?

  1993cited by this paper
• Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme‐linked immunosorbent assay

  1991cited by this paper
• Hepatocyte growth factor: Molecular structure and implications for a central role in liver regeneration

  1991cited by this paper
• Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.

  1990cited by this paper
• Molecular cloning and expression of human hepatocyte growth factor

  1989cited by this paper
• Serum enzyme assays in the diagnosis of acute myocardial infarction

  1987cited by this paper
• Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis.

  1986cited by this paper
• Angiographie morphology and the pathogenesis of unstable angina pectoris

  1985cited by this paper
• Angiographic morphology and the pathogenesis of unstable angina pectoris.

  1985cited by this paper
• Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats.

  1984cited by this paper

• Endothelial Cell Transition: Preliminary Data on Cross-Organ Shift from Brain to Liver

  2025cites this paper
• Differential circulating cytokine profiles in acute coronary syndrome versus stable coronary artery disease

  2024cites this paper
• Hepatocyte growth factor is associated with greater risk of extracoronary calcification: results from the multiethnic study of atherosclerosis

  2022cites this paper
• Cardiovascular biomarkers in body fluids: progress and prospects in optical sensors

  2022cites this paper
• Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation

  2022cites this paper
• Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease to Increased hepatocyte growth factor levels over 2 years are associated with coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).

  2019cites this paper
• Atherosclerosis impacts the link between hepatocyte growth factor and cognition

  2018cites this paper
• Angiogenic growth factors in myocardial infarction: a critical appraisal

  2017cites this paper
• Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease

  2017cites this paper
• Hepatocyte Growth Factor: Cardiotrophic Roles and Potential Therapeutics for Cardiovascular Diseases

  2014cites this paper
• Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling

  2014cites this paper
• Recruitment of mesenchymal stem cells to apoptotic tissue cells is mediated by hepatocyte growth factor

  2014cites this paper
• Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection.

  2013cites this paper
• Hepatocyte growth factor - the earliest marker of myocardial injury in ST-segment elevation myocardial infarction.

  2013cites this paper
• Effects of hepatocyte growth factor overexpressed bone marrow‐derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts

  2012cites this paper
• Clinical Trials in Renal Regenerative Medicine

  2011cites this paper
• A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia

  2011cites this paper
• Knockdown of stromal interaction molecule 1 attenuates hepatocyte growth factor-induced endothelial progenitor cell proliferation

  2010cites this paper
• Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells

  2009cites this paper
• Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage

  2009cites this paper
• Ascertainment of Chronic Diseases in the Canadian Longitudinal Study on Aging (CLSA), Systematic Review*

  2009cites this paper
• Enhancing Efficacy of Stem Cell Transplantation to the Heart with a PEGylated Fibrin Biomatrix

  2008cites this paper
• Cerebrospinal fluid hepatocyte growth factor level in meningitis.

  2008cites this paper
• Activation of Notch-Mediated Protective Signaling in the Myocardium

  2008cites this paper
• Down-regulation of hepatocyte growth factor mRNA in rat cardiac myocytes under hypoxia mimicked by cobalt chloride

  2006cites this paper
• Stem cell activation sustains hereditary hypertrophy in hamster cardiomyopathy

  2005cites this paper
• Candidate‐based proteomics in the search for biomarkers of cardiovascular disease

  2005cites this paper
• The effects of growth hormone status on circulating levels of vascular growth factors

  2005cites this paper
• Angiogenic factors are elevated in overweight and obese individuals

  2005cites this paper
• Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure

  2005cites this paper
• Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor.

  2004cites this paper
• Hepatocyte growth factor and cardiovascular thrombosis in patients admitted to the intensive care unit.

  2004cites this paper
• Influence of Insulin-Like Growth Factor-1 and Hepatocyte Growth Factor on Carotid Atherosclerosis and Cognitive Function in the Elderly

  2004cites this paper
• Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis.

  2003cites this paper
• Growth Factor Signaling for Cardioprotection Against Oxidative Stress-Induced Apoptosis

  2003cites this paper
• Hepatocyte growth factor: from diagnosis to clinical applications.

  2003cites this paper
• Hepatocyte Growth Factor Induces GATA-4 Phosphorylation and Cell Survival in Cardiac Muscle Cells*

  2003cites this paper
• Serum hepatocyte growth factor predicts ventricular remodeling following myocardial infarction.

  2002cites this paper
• Hepatocyte growth factor production may be related to the inflammatory response in patients with acute myocardial infarction.

  2002cites this paper
• Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease.

  2002cites this paper
• Plasma hepatocyte growth factor and the relationship between risk factors and carotid atherosclerosis.

  2002cites this paper
• Focal enhancement of expression of c-Met/hepatocyte growth factor receptor in the myocardium in human myocardial infarction.

  2001cites this paper
• Help from within: cardioprotective properties of hepatocyte growth factor.

  2001cites this paper
• Effects of Thiol Antioxidants on Hepatocyte Growth Factor Signaling in Cardiac Myocytes

  2001cites this paper
• Association between carotid arterial remodeling and plasma concentration of circulating hepatocyte growth factor

  2001cites this paper
• Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis.

  2001cites this paper
• Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease

  2000cites this paper
• Hepatocyte growth factor plasma levels after myocardial infarction are not affected by recombinant tissue-type plasminogen-activator therapy.

  2000cites this paper
• Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes.

  1999cites this paper
• Sequential changes of hepatocyte growth factor in the serum and enhanced c-Met expression in the myocardium in acute myocardial infarction.

  1999cites this paper